NEW DELHI: To ensure there is no compromise in patient safety, the Federation of Indian Chambers of Commerce & Industry (FICCI) has requested the Central government to notify the Draft e-Pharmacy Rules at the earliest.
Mr Prashant Tandon, Chairperson, FICCI e-Pharmacy Working Group, has said, “The delay in notifying the e-Pharmacy rules is causing a lot of issues for the e-Pharmacy players in terms of ease of doing business, as a simple and clear regulatory pathway is a prerequisite for innovation to thrive in this important sector.”
Mr Tandon said, “We hope the government would take into account the importance of digitization in healthcare space which eventually leads to an empowered consumer.”
He pointed out, “All the orders for prescription-based medicines are processed only against a copy of valid prescription and are dispensed by a licensed pharmacy having a registered pharmacist. e-Pharmacies strictly do not accept orders for habit forming medicines, narcotics, or any other sensitive medicines.”
“There is no violation of any existing act and rules in current e-Pharmacy model. However, there are certain difficulties that the sector has been facing towards ease of doing business due to regulatory uncertainty. This is because of the pending Draft e-Pharmacy Rules. e-Pharmacy Draft Rules Provide Sector Specific e-Commerce regulations - aim to harmonize existing laws/guidelines,” Mr Tandon added.
He said, “FICCI supported the industry to come up with a 'Code of Conduct' for e-Pharmacies in the country to ensure proper compliance and high standards of operation.”